Advertisement

Topics

Novartis launches first large-scale smartphone-based study in multiple sclerosis

04:55 EDT 23 Aug 2017 | Pharmafile

Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis (MS) from patients via their smartphones, removing the need for them to visit a medical professional at the clinic.

The study, known as ‘Evaluation of evidence from smart phone sensors and patient-reported outcomes in participants with multiple sclerosis’, or elevateMS, is designed to gather data on the challenges faced by sufferers of MS on a daily basis, in order to develop more effective gauges of treatment effectiveness.  

read more

Original Article: Novartis launches first large-scale smartphone-based study in multiple sclerosis

NEXT ARTICLE

More From BioPortfolio on "Novartis launches first large-scale smartphone-based study in multiple sclerosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...